Author:
Wang Yue,Wang Yadi,Li Xueling,Gao Yu,Pan Xiaohong,Lü Junhong
Funder
NSAF Joint Fund of the National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Escriba, P. V., Busquets, X., Inokuchi, J., Balogh, G., Torok, Z., Horvath, I., Harwood, J. L., & Vigh, L. (2015). Membrane lipid therapy: Modulation of the cell membrane composition and structure as a molecular base for drug discovery and new disease treatment. Progress in Lipid Research, 59, 38–53.
2. Zalba, S., & ten Hagen, T. L. M. (2017). Cell membrane modulation as adjuvant in cancer therapy. Cancer Treatment Reviews, 52, 48–57.
3. Preta, G. (2020). New insights into targeting membrane lipids for cancer therapy. Frontiers in Cell and Developmental Biology, 8, 571237.
4. Hryniewicz-Jankowska, A., Augoff, K., Biernatowska, A., Podkalicka, J., & Sikorski, A. F. (2014). Membrane rafts as a novel target in cancer therapy. Biochimica et Biophysica Acta, 1845(2), 155–165.
5. Mollinedo, F. & Gajate, C. (2015). Lipid rafts as major platforms for signaling regulation in cancer. Advances in Biological Regulation, 57, 130–46.